A61P 41/00
Drugs used in surgical methods
Official title: Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
A61P41/00 (Drugs used in surgical methods) appears on 1,715 US grants and 2,807 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,715
- Published applications
- 2,807
- Assignees
- 1,279
- Inventors
- 4,804
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 6 | 0 |
| 1997 | 11 | 0 |
| 1998 | 19 | 0 |
| 1999 | 18 | 0 |
| 2000 | 28 | 0 |
| 2001 | 33 | 16 |
| 2002 | 60 | 83 |
| 2003 | 46 | 122 |
| 2004 | 56 | 147 |
| 2005 | 30 | 172 |
| 2006 | 61 | 128 |
| 2007 | 45 | 140 |
| 2008 | 62 | 194 |
| 2009 | 74 | 181 |
| 2010 | 83 | 179 |
| 2011 | 98 | 181 |
| 2012 | 115 | 216 |
| 2013 | 117 | 143 |
| 2014 | 138 | 116 |
| 2015 | 107 | 112 |
| 2016 | 91 | 109 |
| 2017 | 79 | 87 |
| 2018 | 56 | 71 |
| 2019 | 56 | 74 |
| 2020 | 42 | 71 |
| 2021 | 41 | 55 |
| 2022 | 39 | 68 |
| 2023 | 25 | 59 |
| 2024 | 31 | 37 |
| 2025 | 28 | 25 |
| 2026 | 12 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Radiopaque polymers with enhanced radiopacity15 Sep 2026US 12,734,255 B2Embolization, Inc.
- Low endotoxin fucan compositions, systems and methods25 Aug 2026US 12,714,724 B2ARC Medical Inc.
- Use of inhibitors of the activator protein 1 (AP-1) for preventing adhesions7 Jul 2026US 12,673,043 B2The Board of Trustees of the Leland Stanford Junior University
- Vascular embolic system19 May 2026US 12,629,446 B23-D Matrix, Ltd.
- Methods of administering safe colon cleansing compositions7 Apr 2026US 12,594,298 B2Azurity Pharmaceuticals, Inc.
- Perfluorocarbon compositions, systems, and methods for ischemic, inflammatory, infectuous, transplant, and other medical conditions8 Oct 2026US 2026/0306422 A1
- Therapeutic window for citrulline therapy3 Sep 2026US 2026/0256724 A1Asklepion Pharmaceuticals, LLC
- Non-Enzymatic Debriding Agent and Method of Use Thereof27 Aug 2026US 2026/0248749 A1Alira Health Boston LLC
- Peptides and hydrogels for treating corneal diseases20 Aug 2026US 2026/0241071 A1Ottawa Heart Institute Research Corporation
- Ophthalmic composition for ocular surgery preparation in patients with ocular surface disease13 Aug 2026US 2026/0232757 A1
Most cited
By later US patents
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009
- Methods for forming regional tissue adherent barriers and drug delivery systems368US 6,514,534 B1Incept, LLC · 2003
- Biocompatible crosslinked polymers366US 6,566,406 B1Incept, LLC · 2003
- Downmodulating an immune response with multivalent antibodies to PD-1309US 6,808,710 B1Dana-Farber Cancer Institute, Inc. · 2004
- Methods of indirectly stimulating the vagus nerve with an electrical field284US 6,778,854 B22004